RFC
ACUR

Russell Frank Company’s Acura Pharmaceuticals ACUR Stock Holding History

Russell Frank Company’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15
Closed – – 3520
2013
Q2 		$0 Buy
+15
New +$169 ﹤0.01% 3392

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $692M AUM 5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's ACUR Position: Q3 2013 in Review

Russell Frank Company sold out of Acura Pharmaceuticals (ACUR) in Q3 2013, closing a stake of 15 shares.

Russell Frank Company first reported a position in ACUR in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 30 funds tracked by Wall St. Rank hold ACUR as of Q3 2013.

  • Russell Frank Company reported no remaining Acura Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Russell Frank Company sold 15 Acura Pharmaceuticals shares in Q3 2013.
  • Russell Frank Company first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Russell Frank Company's Acura Pharmaceuticals position peaked at $0 in Q2 2013.
  • 30 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2013.

Based on Russell Frank Company's 13F filing for Q3 2013, filed 29 Oct 2013.